Skip to main content

James Crowe Jr.

Core facilities key driver of VUMC research gains

Jan. 29, 2015—During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care.

Read more


VUCast: Why overweight women lose at work

Dec. 1, 2014—In the latest VUCast: Learn why overweight women lose in the workplace -- especially when it comes to pay; see breakthrough weapons in the fight against infectious diseases; and hear music legend Sheryl Crow speak about her craft. Watch now!

Read more


Ambassadors visit Vanderbilt, review research

Oct. 31, 2014—Ambassadors from 26 nations visited Vanderbilt Oct. 31 and heard from Chancellor Nicholas S. Zeppos and two researchers about their work.

Read more


Vanderbilt researchers isolate Ebola-fighting human antibodies for possible treatment

Oct. 28, 2014—Vanderbilt University researchers have isolated Ebola-fighting human antibodies – the first of their kind – that could lead to a new treatment for the deadly virus.

Read more


Vanderbilt’s Brown, Crowe elected to IOM

Oct. 21, 2014—  Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization announced this week. With more than 1,900 active members and foreign associates, the IOM...

Read more


Alexander’s visit highlights efforts to confront Ebola

Sep. 24, 2014—Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

Read more


Initiative seeks to develop therapies to combat Ebola

Sep. 18, 2014—Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.

Read more


Cutting-edge research to be showcased in May

May. 1, 2014—Potentially “game-changing” research at Vanderbilt University on infectious diseases, population health and health policy will be showcased during two interactive presentations May 15 and May 22. A segment of the Flexner Discovery Lecture Series, the new “Vanderbilt Cutting-edge Discovery” discussions are highlights of recent presentations to the Vanderbilt Biomedical Science Advisory Board, a group of...

Read more


Vanderbilt Vaccine Center joins global task force to address urgent viral threat

Apr. 7, 2014—World Health Day 2014 Shines Spotlight on Mosquito-borne Viral Diseases Chikungunya virus, a vector-borne disease that is quickly spread by mosquitoes and causes victims to suffer severe fever and pain, has reached the Caribbean and South America—and is predicted to soon cause outbreaks in the United States. For many years the virus has remained primarily...

Read more


Multi-center effort targets lethal Ebola, Marburg viruses

Mar. 6, 2014—Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.

Read more


Discovery may pave way for RSV vaccine

Feb. 5, 2014—Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.

Read more


Nine faculty honored with endowed chairs

Jan. 24, 2014—Nine Vanderbilt University faculty members named to endowed chairs were honored for their academic achievements during a celebration Jan. 22 at the Student Life Center.

Read more


VIEW MORE EVENTS >